20-45314116-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014276.4(RBPJL):c.839C>T(p.Thr280Met) variant causes a missense change. The variant allele was found at a frequency of 0.000428 in 1,614,030 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars).
Frequency
Genomes: 𝑓 0.00049 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00042 ( 1 hom. )
Consequence
RBPJL
NM_014276.4 missense
NM_014276.4 missense
Scores
2
9
7
Clinical Significance
Conservation
PhyloP100: 7.14
Genes affected
RBPJL (HGNC:13761): (recombination signal binding protein for immunoglobulin kappa J region like) This gene encodes a member of the suppressor of hairless protein family. A similar protein in mouse is a transcription factor that binds to DNA sequences almost identical to that bound by the Notch receptor signaling pathway transcription factor recombining binding protein J. The mouse protein has been shown to activate transcription in concert with Epstein-Barr virus nuclear antigen-2. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009372294).
BS2
High AC in GnomAd4 at 74 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBPJL | NM_014276.4 | c.839C>T | p.Thr280Met | missense_variant | 8/12 | ENST00000343694.8 | NP_055091.2 | |
RBPJL | NM_001281449.2 | c.839C>T | p.Thr280Met | missense_variant | 8/12 | NP_001268378.1 | ||
RBPJL | NM_001281448.2 | c.839C>T | p.Thr280Met | missense_variant | 8/12 | NP_001268377.1 | ||
RBPJL | XM_011528522.3 | c.839C>T | p.Thr280Met | missense_variant | 8/12 | XP_011526824.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBPJL | ENST00000343694.8 | c.839C>T | p.Thr280Met | missense_variant | 8/12 | 1 | NM_014276.4 | ENSP00000341243 | A1 | |
RBPJL | ENST00000372743.5 | c.839C>T | p.Thr280Met | missense_variant | 8/12 | 1 | ENSP00000361828 | P4 | ||
RBPJL | ENST00000372741.7 | c.839C>T | p.Thr280Met | missense_variant | 8/12 | 1 | ENSP00000361826 | |||
RBPJL | ENST00000464504.2 | c.83C>T | p.Thr28Met | missense_variant | 1/5 | 3 | ENSP00000483978 |
Frequencies
GnomAD3 genomes AF: 0.000466 AC: 71AN: 152232Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
71
AN:
152232
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00166 AC: 418AN: 251118Hom.: 0 AF XY: 0.00124 AC XY: 168AN XY: 135810
GnomAD3 exomes
AF:
AC:
418
AN:
251118
Hom.:
AF XY:
AC XY:
168
AN XY:
135810
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000421 AC: 616AN: 1461680Hom.: 1 Cov.: 31 AF XY: 0.000358 AC XY: 260AN XY: 727176
GnomAD4 exome
AF:
AC:
616
AN:
1461680
Hom.:
Cov.:
31
AF XY:
AC XY:
260
AN XY:
727176
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000486 AC: 74AN: 152350Hom.: 0 Cov.: 33 AF XY: 0.000470 AC XY: 35AN XY: 74498
GnomAD4 genome
AF:
AC:
74
AN:
152350
Hom.:
Cov.:
33
AF XY:
AC XY:
35
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
147
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: risk factor
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Type 2 diabetes mellitus Other:1
risk factor, no assertion criteria provided | case-control | Diabetes Molecular Genetics Section, Phoenix Epidemiology and Clinical Research Branch, National Institutes of Health | - | The variant allele associates with increased risk of T2D. In in-vtro studies the variant allele reduces protein expression and also effects tranactivation capability - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;M
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
1.0
.;D;D
Vest4
MVP
MPC
1.2
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at